Categories: Awareness

Study says Decidualization defects has direct relation to Preeclampsia

New Delhi, March 29, 2018: A scientific study led by father of genetics Dr. Carlos Simon has said that there is a connection between the changes in cells of the endometrium in preparation for, and during (decidualization) pregnancy is related to high blood pressure in pregnancy (preeclampsia).

  • Until now, research efforts to understand why preeclampsia occurs had been focused on studying the placenta.
  • Our study shows that a defect in the decidualization process of the endometrium may be one of the causes of preeclampsia.
  • It broadens the possibility of developing the early diagnosis of preeclampsia by identifying this decidualization defect.

Preeclampsia is a severe complication that occurs in the third trimester or 20 weeks of pregnancy, affecting around 8% of the total pregnant women.

If  not diagnosed on time, it may lead to significant complications with both the mother and foetus during the pregnancy. Until now, most research on the topic had focused on investigating defects in placenta formation that resulted in the onset of the disease, ignoring the role of the maternal uterine tissue where the embryo is implanted.

Our study shows the link between the onset of preeclampsia and a defect in the decidualization process in the endometrium. Decidualization is an endometrial process that entails preparing the uterus for the implantation of the embryo and a successful pregnancy. This defect not only occurs in the endometrium of women who have suffered from preeclampsia during a previous pregnancy, but also in patients who have preeclampsia at the time of birth.

This discovery offers an explanation as to why women with preeclampsia are more prone to a recurrence of this condition

in future pregnancies. This study paves the way towards developing a clinical diagnosis that facilitates the prospective risk assessment

of suffering from preeclampsia and the possible treatment of this condition before pregnancy.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

2 days ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

2 days ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

3 days ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

3 days ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

4 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

4 days ago